Seroepidemiology of middle east respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity

Eurosurveillance

Volumn 19, Issue 23, 2014, Pages

  Hemida, M G ^a,b   Perera, R A ^c   Al Jassim, R A ^d   Kayali, G ^e   Siu, L Y ^f   Wang, P ^f,g   Chu, K W ^c   Perlman, S ^h   Ali, M A ⁱ   Alnaeem, A ^a   Guan, Y ^c   Poon, L L ^c   Saif, L ^j   Peiris, M ^c,f  

^a KING FAISAL UNIVERSITY   (Saudi Arabia)

^b KAFRELSHEIKH UNIVERSITY   (Egypt)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^f HKU PASTEUR RESEARCH CENTRE   (Hong Kong)

^g UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^h UNIVERSITY OF IOWA   (United States)

ⁱ NATIONAL RESEARCH CENTRE   (Egypt)

^j OHIO STATE UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; AUSTRALIA; CORONAVIRUS; CROSS REACTION; DROMEDARY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE SEQUENCE; MIDDLE EAST RESPIRATORY SYNDROME; NONHUMAN; RESPIRATORY DISTRESS SYNDROME; SAUDI ARABIA; SEROEPIDEMIOLOGY; VIRUS NEUTRALIZATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; AUSTRALIA; CAMELS; CATTLE; CORONAVIRUS; CORONAVIRUS INFECTIONS; HUMANS; IMMUNOGLOBULIN G; NEUTRALIZATION TESTS; PREVALENCE; RESPIRATORY TRACT INFECTIONS; SAUDI ARABIA; SEROEPIDEMIOLOGIC STUDIES;

EID: 84902239619     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2014.19.23.20828     Document Type: Article

References (22)

1. World Health Organization (WHO). Middle East respiratory syndrome coronavirus (MERS-CoV) summary and literature update - as of 9 May 2014. Geneva:WHO. [Accessed 30 May 2014]. Available from: http://www.who.int/csr/disease/coronavirus_infections/MERS_CoV_Update_09_May_2014.pdf
2. Xu RH, He JF, Evans MR, Peng GW, Field HE, Yu DW, et al. Epidemiologic clues to SARS origin in China. Emerg Infect Dis. 2004;10(6):1030-7. http://dx.doi.org/10.3201/eid1006.030852
3. Sims LD, Peiris M. One health: the Hong Kong experience with avian influenza. Curr Top Microbiol Immunol. 2013;365:281-98. http://dx.doi.org/10.1007/82_2012_254
4. Peiris JSM, Guan Y, Yuen KY. Severe acute respiratory syndrome. Nat Med. 2004;10(12 Suppl):S88-97. http://dx.doi.org/10.1038/nm1143
5. Reusken CB, Haagmans BL, Müller MA, Gutierrez C, Godeke GJ, Meyer B, et al. Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect Dis. 2013;13(10):859-66. http://dx.doi.org/10.1016/S1473-3099(13)70164-6
6. Perera RA, Wang P, Gomaa MR, El-Shesheny R, Kandeil A, Bagato O, et al. Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. Euro Surveill. 2013;18(36):pii=20574.
7. Alexandersen S, Kobinger GP, Soule G, Wernery U. Middle East respiratory syndrome coronavirus antibody reactors among camels in Dubai, United Arab Emirates, in 2005. Transbound Emerg Dis. 2014;61(2):105-8. http://dx.doi.org/10.1111/tbed.12212
8. Reusken CBEM, Messadi L, Feyisa A, Ularamu H, Godeke GJ, Danmarwa A, et al. Geographic distribution of MERS coronavirus among dromedary camels, Africa. Emerg Infect Dis. 2014. [Epub ahead of print]. http://dx.doi.org/10.3201/eid2007.140590
9. Haagmans BL, Al Dhahiry SH, Reusken CB, Raj VS, Galiano M, Myers R, et al. Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation. Lancet Infect Dis. 2014;14(2):140-5. http://dx.doi.org/10.1016/S1473-3099(13)70690-X
10. Chu DKW, Poon LLM, Gomaa MM, Shehata MM, Perera RA, Zeid DA et al. MERS coronaviruses in dromedary camels, Egypt. Emerg Infect Dis. 2014;20(6):1049-53. http://dx.doi.org/10.3201/eid2006.140299
11. Alagaili AN, Briese T, Mishra N, Kapoor V, Sameroff SC, Burbelo PD, et al. Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia. MBio. 2014;5(2):e00884-14. http://dx.doi.org/10.1128/mBio.01002-14
12. Hemida MG, Chu DKW, Poon LLM, Perera RAPM, Alhammadi MA, Ng H-Y, et al. MERS coronavirus in dromedary camel herd, Saudi Arabia. Emerg Infect Dis. 2014 Jul. [Epub ahead of print]. http://wwwnc.cdc.gov/eid/article/20/7/14-0571_article.htm
13. Hemida MG, Perera RA, Wang P, Alhammadi MA, Siu LY, Li M, et al. Middle East Respiratory Syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013. Euro Surveill. 2013;18(50):pii=20659.
14. Reusken CB, Ababneh M, Raj VS, Meyer B, Eljarah A, Abutarbush S, et al. Middle East Respiratory Syndrome coronavirus (MERS-CoV) serology in major livestock species in an affected region in Jordan, June to September 2013. Euro Surveill. 2013;18(50):pii=20662.
15. Memish ZA, Cotten M, Meyer B, Watson SJ, Alsahafi AJ, Al Rabeeah AA, et al. Human Infection with MERS Coronavirus after Exposure to Infected Camels, Saudi Arabia, 2013. Emerg Infect Dis. 2014;20(6):1012-5. http://dx.doi.org/10.3201/eid2006.140402
16. Meyer B, Müller MA, Corman VM, Reusken CB, Ritz D, Godeke GJ, et al. Antibodies against MERS coronavirus in dromedary camels, United Arab Emirates, 2003 and 2013. Emerg Infect Dis. 2014;20(4):552-9. http://dx.doi.org/10.3201/eid2004.131746
17. Wesolowski J, Alzogaray V, Reyelt J, Unger M, Juarez K, Urrutia M, et al. Single domain antibodies: promising experimental and therapeutic tools in infection and immunity. Med Microbiol Immunol. 2009;198(3):157-74. http://dx.doi.org/10.1007/s00430-009-0116-7
18. Horzinek MC, Lutz H, Pedersen NC. Antigenic relationships among homologous structural polypeptides of porcine, feline, and canine coronaviruses. Infect Immun. 1982;37(3):1148-55.
19. Shao X, Guo X, Esper F, Weibel C, Kahn JS. Seroepidemiology of group I human coronaviruses in children. J Clin Virol. 2007;40(3):207-13. http://dx.doi.org/10.1016/j.jcv.2007.08.007
20. Chan CM, Tse H, Wong SS, Woo PC, Lau SK, Chen L, et al. Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus. J Clin Virol. 2009;45(1):54-60. http://dx.doi.org/10.1016/j.jcv.2009.02.011
21. Corman VM, Jores J, Meyer B, Younan M, Liljander A, Said MY, et al. Antibodies against MERS coronavirus in dromedary camels, Kenya, 1992-2013. Emerg Infect Dis. 2014. [Epub ahead of print]. http://dx.doi.org/10.3201/eid2008.140596
22. Australian Government, Department of Sustainability, Environment, Water, Population and Communities. National Feral Camel Action Plan. Camberra: Natural Resource Management Ministerial Council. Available from: http://www.environment.gov.au/system/files/resources/2060c7a8-088f-415d-94c8-5d0d657614e8/files/feral-camel-action-plan.pdf